![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
EFFECT OF MULTIPLE ORAL DOSES OF FALDAPREVIR ON THE MULTIPLE DOSE PHARMACOKINETICS OF A COMBINATION ORAL TABLET OF ETHINYLESTRADIOL AND LEVONORGESTREL IN HEALTHY PREMENOPAUSAL FEMALE VOLUNTEERS
|
|
|
Reported by Jules Levin
AASLD 2013 Nov 1-4 Wash DC
JP Sabo1, B Lang2, M Elgadi3, F Huang11Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA; 2Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany; 3Boehringer Ingelheim (Canada) Ltd/Ltée, Burlington, ON, Canada
![AASLD1.gif](../images/111013/111013-2/AASLD1.gif)
![AASLD2.gif](../images/111013/111013-2/AASLD2.gif)
![AASLD3.gif](../images/111013/111013-2/AASLD3.gif)
![AASLD4.gif](../images/111013/111013-2/AASLD4.gif)
![AASLD5.gif](../images/111013/111013-2/AASLD5.gif)
![AASLD6.gif](../images/111013/111013-2/AASLD6.gif)
![AASLD7.gif](../images/111013/111013-2/AASLD7.gif)
![AASLD8.gif](../images/111013/111013-2/AASLD8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|